
Perspective Therapeutics Inc
CATXNYSE MKT LLCKey Statistics
Open
$4.06
Day High
$4.15
Day Low
$3.90
Prev. Close
$4.05
VolumeShares traded today.
874.70K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$449.34M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-2.81
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$6.16
52W LowLowest price over the past 52 weeks.
$1.96
50D MAAverage closing price over the last 50 trading days.
$4.14
200D MAAverage closing price over the last 200 trading days.
$3.63
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+1.8%1M
+0.3%6M
+79.9%YTD
+41.2%1Y
+53.3%About
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.
www.perspectivetherapeutics.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CATX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.